Capital Rx is based in New York. It has raised $400M in total funding. Latest round: Series F. Backed by Wellington Management, General Catalyst, Generation.
Capital Rx is based in New York. Capital Rx has raised $400M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series F announced in September 2025. The round record for Capital Rx runs through 2025; nothing later has been disclosed. Investors on record include Wellington Management, General Catalyst, Generation. 3 distinct backers are named across the disclosed rounds.
Capital Rx totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in New York below to benchmark round size and investor mix.
Company funding database · Investor directory · Founder database · Mega-rounds 2026